PKM2 Promotes Reductive Glutamine Metabolism

This study investigated how cancer cells change their metabolism to survive and grow. Researchers focused on an enzyme called PKM2, which plays a key role in how cells process glucose (sugar). They wanted to understand why cancer cells often prefer a less efficient way of using glucose called "aerobic glycolysis" or the "Warburg effect."

Using laboratory techniques, the scientists found that PKM2 is particularly good at converting glucose into lactate, which is more efficient than another similar enzyme called PKM1. However, this process uses up glucose quickly, leaving less available for other important cellular functions. When glucose becomes scarce, PKM2 helps cells switch to using glutamine, an amino acid, as an alternative fuel source through a process called "reductive glutamine metabolism."

This metabolic flexibility is important because it helps cells survive in challenging conditions, such as when oxygen levels are low (hypoxia). The researchers found that this ability to switch between fuel sources supports tumor growth in mice, suggesting this mechanism helps cancer cells thrive in the harsh environment inside tumors.

While this research focused on cancer cells, understanding these metabolic pathways is relevant for general metabolic health. The enzymes and processes studied here are present in normal cells too, and this knowledge helps explain how our cells adapt their energy production based on available resources. For clinical practice, this research may eventually inform strategies for optimizing cellular metabolism and understanding how our bodies respond to different nutritional states.